title: Developing discriminate model and comparative analysis of differentially expressed genes and pathways for bloodstream samples of diabetes mellitus type 2.
abstract: BACKGROUND
  Diabetes mellitus of type 2 (T2D), also known as noninsulin-dependent diabetes mellitus (NIDDM) or adult-onset diabetes, is a common disease. It is estimated that more than 300 million people worldwide suffer from T2D. In this study, we investigated the T2D, pre-diabetic and healthy human (no diabetes) bloodstream samples using genomic, genealogical, and phonemic information. We identified differentially expressed genes and pathways. The study has provided deeper insights into the development of T2D, and provided useful information for further effective prevention and treatment of the disease.
  
  
  RESULTS
  A total of 142 bloodstream samples were collected, including 47 healthy humans, 22 pre-diabetic and 73 T2D patients. Whole genome scale gene expression profiles were obtained using the Agilent Oligo chips that contain over 20,000 human genes. We identified 79 significantly differentially expressed genes that have fold change ≥ 2. We mapped those genes and pinpointed locations of those genes on human chromosomes. Amongst them, 3 genes were not mapped well on the human genome, but the rest of 76 differentially expressed genes were well mapped on the human genome. We found that most abundant differentially expressed genes are on chromosome one, which contains 9 of those genes, followed by chromosome two that contains 7 of the 76 differentially expressed genes. We performed gene ontology (GO) functional analysis of those 79 differentially expressed genes and found that genes involve in the regulation of cell proliferation were among most common pathways related to T2D. The expression of the 79 genes was combined with clinical information that includes age, sex, and race to construct an optimal discriminant model. The overall performance of the model reached 95.1% accuracy, with 91.5% accuracy on identifying healthy humans, 100% accuracy on pre-diabetic patients and 95.9% accuract on T2D patients. The higher performance on identifying pre-diabetic patients was resulted from more significant changes of gene expressions among this particular group of humans, which implicated that patients were having profound genetic changes towards disease development.
  
  
  CONCLUSIONS
  Differentially expressed genes were distributed across chromosomes, and are more abundant on chromosomes 1 and 2 than the rest of the human genome. We found that regulation of cell proliferation actually plays an important role in the T2D disease development. The predictive model developed in this study has utilized the 79 significant genes in combination with age, sex, and racial information to distinguish pre-diabetic, T2D, and healthy humans. The study not only has provided deeper understanding of the disease molecular mechanisms but also useful information for pathway analysis and effective drug target identification.
authors.forename: Chang
authors.initials: C
authors.lastname: Liu
authors.forename: Lili
authors.initials: L
authors.lastname: Lu
authors.forename: Quan
authors.initials: Q
authors.lastname: Kong
authors.forename: Yan
authors.initials: Y
authors.lastname: Li
authors.forename: Haihua
authors.initials: H
authors.lastname: Wu
authors.forename: William
authors.initials: W
authors.lastname: Yang
authors.forename: Shandan
authors.initials: S
authors.lastname: Xu
authors.forename: Xinyu
authors.initials: X
authors.lastname: Yang
authors.forename: Xiaolei
authors.initials: X
authors.lastname: Song
authors.forename: Jack Y
authors.initials: JY
authors.lastname: Yang
authors.forename: Mary
authors.initials: M
authors.lastname: Yang
authors.forename: Youping
authors.initials: Y
authors.lastname: Deng
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000097:blood*; D016022:Case-Control Studies; D002877:Chromosomes, Human; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000235:genetics*; D020869:Gene Expression Profiling; D015894:Genome, Human; D006801:Humans; D015233:Models, Statistical; D020411:Oligonucleotide Array Sequence Analysis; D011236:Prediabetic State / Q000097:blood / Q000235:genetics*; D012333:RNA, Messenger / Q000235:genetics; D015398:Signal Transduction
chemical_list: D015415:Biomarkers; D012333:RNA, Messenger